{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2024,2,10]],"date-time":"2024-02-10T00:22:10Z","timestamp":1707524530912},"reference-count":30,"publisher":"Springer Science and Business Media LLC","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2022,1,9]]},"DOI":"10.7759\/cureus.21042","type":"journal-article","created":{"date-parts":[[2022,1,9]],"date-time":"2022-01-09T09:18:00Z","timestamp":1641719880000},"source":"Crossref","is-referenced-by-count":0,"title":["Evaluation of Optic Nerve Head Parameters and Electro-Physiology Among Breast Cancer Patients on Tamoxifen"],"prefix":"10.7759","author":[{"given":"Qi Zhe","family":"Ngoo","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Wan Hazabbah","family":"Wan Hitam","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Chai Lee","family":"Tan","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Venkata Murali","family":"Krishna Bhavaraju","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","reference":[{"key":"ref1","doi-asserted-by":"publisher","DOI":"10.1016\/S0140-6736(05)66544-0","article-title":"Effects of chemotherapy and hormonal therapy for early breast cancer on recurrence and 15-year survival: an overview of the randomised trials","volume":"365","year":"2005","unstructured":"Effects of chemotherapy and hormonal therapy for early breast cancer on recurrence and 15-year survival. an overview of the randomised trials. Lancet. 2005, 365:1687-717. 10.1016\/S0140-6736(05)66544-0","journal-title":"Lancet"},{"key":"ref2","doi-asserted-by":"publisher","DOI":"10.1016\/j.pharmthera.2013.05.005","article-title":"Toxicity and adverse effects of tamoxifen and other anti-estrogen drugs","volume":"139","author":"Yang G","year":"2013","unstructured":"Yang G, Nowsheen S, Aziz K, Georgakilas AG. Toxicity and adverse effects of tamoxifen and other anti-estrogen drugs. Pharmacol Ther. 2013, 139:392-404. 10.1016\/j.pharmthera.2013.05.005","journal-title":"Pharmacol Ther"},{"key":"ref3","article-title":"Tamoxifen for early breast cancer: an overview of the randomised trials. Early Breast Cancer Trialists' Collaborative Group","volume":"351","year":"1998","unstructured":"Tamoxifen for early breast cancer. an overview of the randomised trials. Early Breast Cancer Trialists' Collaborative Group. Lancet. 1998, 351:1451-67.","journal-title":"Lancet"},{"key":"ref4","article-title":"Polychemotherapy for early breast cancer: an overview of the randomised trials. Early Breast Cancer Trialists' Collaborative Group","volume":"352","year":"1998","unstructured":"Polychemotherapy for early breast cancer. an overview of the randomised trials. Early Breast Cancer Trialists' Collaborative Group. Lancet. 1998, 352:930-42.","journal-title":"Lancet"},{"key":"ref5","doi-asserted-by":"publisher","DOI":"10.1093\/jnci\/90.18.1371","article-title":"Tamoxifen for prevention of breast cancer: report of the National Surgical Adjuvant Breast and Bowel Project P-1 Study","volume":"90","author":"Fisher B","year":"1998","unstructured":"Fisher B, Costantino JP, Wickerham DL, et al.. Tamoxifen for prevention of breast cancer: report of the National Surgical Adjuvant Breast and Bowel Project P-1 Study. J Natl Cancer Inst. 1998, 90:1371-88. 10.1093\/jnci\/90.18.1371","journal-title":"J Natl Cancer Inst"},{"key":"ref6","doi-asserted-by":"publisher","DOI":"10.1016\/s0161-6420(81)35071-4","article-title":"Tamoxifen retinopathy. A clinicopathologic report","volume":"88","author":"Kaiser-Kupfer MI","year":"1981","unstructured":"Kaiser-Kupfer MI, Kupfer C, Rodrigues MM. Tamoxifen retinopathy. A clinicopathologic report. Ophthalmology. 1981, 88:89-93. 10.1016\/s0161-6420(81)35071-4","journal-title":"Ophthalmology"},{"key":"ref7","doi-asserted-by":"crossref","DOI":"10.1002\/1097-0142(19920615)69:12<2961::AID-CNCR2820691215>3.0.CO;2-W","article-title":"Clear evidence that long-term, low-dose tamoxifen treatment can induce ocular toxicity a prospective study of 63 patients","volume":"69","author":"Pavlidis NA","year":"1992","unstructured":"Pavlidis NA, Petris C, Briassoulis E, Klouvas G, Psilas C, Rempapis J, Petroutsos G. Clear evidence that long-term, low-dose tamoxifen treatment can induce ocular toxicity a prospective study of 63 patients. Cancer. 1992, 69:2961-4.","journal-title":"Cancer"},{"key":"ref8","doi-asserted-by":"crossref","DOI":"10.1002\/1097-0142(19880101)61:1<33::AID-CNCR2820610107>3.0.CO;2-I","article-title":"Reversible ocular toxicity related to tamoxifen therapy","volume":"61","author":"Ashford AR","year":"1988","unstructured":"Ashford AR, Donev I, Tiwari RP, Garrett T. Reversible ocular toxicity related to tamoxifen therapy. Cancer. 1988, 61:33-5.","journal-title":"Cancer"},{"key":"ref9","doi-asserted-by":"publisher","DOI":"10.1038\/eye.1999.217","article-title":"Ocular toxicity in low-dose tamoxifen: a prospective study","volume":"13 ( Pt 6)","author":"Noureddin BN","year":"1999","unstructured":"Noureddin BN, Seoud M, Bashshur Z, Salem Z, Shamseddin A, Khalil A. Ocular toxicity in low-dose tamoxifen: a prospective study. Eye (Lond). 1999, 13 ( Pt 6):729-33. 10.1038\/eye.1999.217","journal-title":"Eye (Lond)"},{"key":"ref10","doi-asserted-by":"publisher","DOI":"10.1136\/bjo.65.3.177","article-title":"Tamoxifen retinopathy","volume":"65","author":"McKeown CA","year":"1981","unstructured":"McKeown CA, Swartz M, Blom J, Maggiano JM. Tamoxifen retinopathy. Br J Ophthalmol. 1981, 65:177-9. 10.1136\/bjo.65.3.177","journal-title":"Br J Ophthalmol"},{"key":"ref11","doi-asserted-by":"publisher","DOI":"10.1016\/s0002-9394(99)80190-1","article-title":"Long-term tamoxifen citrate use and potential ocular toxicity","volume":"125","author":"Gorin MB","year":"1998","unstructured":"Gorin MB, Day R, Costantino JP, et al.. Long-term tamoxifen citrate use and potential ocular toxicity. Am J Ophthalmol. 1998, 125:493-501. 10.1016\/s0002-9394(99)80190-1","journal-title":"Am J Ophthalmol"},{"key":"ref12","article-title":"Tamoxifen retinopathy","volume":"62","author":"Kaiser-Kupfer MI","year":"1978","unstructured":"Kaiser-Kupfer MI, Lippman ME. Tamoxifen retinopathy. Cancer Treat Rep. 1978, 62:315-20.","journal-title":"Cancer Treat Rep"},{"key":"ref13","doi-asserted-by":"publisher","DOI":"10.1089\/jop.2012.0050","article-title":"The eyes have it! Tamoxifen maculopathy revisited: a case report","volume":"28","author":"Nair AG","year":"2012","unstructured":"Nair AG, Das D, Goyal A, Gandhi RA. The eyes have it! Tamoxifen maculopathy revisited: a case report. J Ocul Pharmacol Ther. 2012, 28:640-2. 10.1089\/jop.2012.0050","journal-title":"J Ocul Pharmacol Ther"},{"key":"ref14","doi-asserted-by":"publisher","DOI":"10.1080\/02713680701229638","article-title":"Multifocal electroretinography, color discrimination and ocular toxicity in tamoxifen use","volume":"32","author":"Salom\u00e3o SR","year":"2007","unstructured":"Salom\u00e3o SR, Watanabe SE, Berezovsky A, Motono M. Multifocal electroretinography, color discrimination and ocular toxicity in tamoxifen use. Curr Eye Res. 2007, 32:345-52. 10.1080\/02713680701229638","journal-title":"Curr Eye Res"},{"key":"ref15","doi-asserted-by":"publisher","DOI":"10.1002\/1097-0142(19860715)58:2<383::aid-cncr2820580232>3.0.co;2-i","article-title":"Bilateral optic neuritis evolved during tamoxifen treatment","volume":"58","author":"Pugesgaard T","year":"1986","unstructured":"Pugesgaard T, Von Eyben FE. Bilateral optic neuritis evolved during tamoxifen treatment. Cancer. 1986, 58:383-6. 10.1002\/1097-0142(19860715)58:2&lt;383::aid-cncr2820580232&gt;3.0.co;2-i","journal-title":"Cancer"},{"key":"ref16","doi-asserted-by":"publisher","DOI":"10.1001\/archopht.124.7.1046","article-title":"A case of tamoxifen keratopathy","volume":"124","author":"Zinchuk O","year":"2006","unstructured":"Zinchuk O, Watanabe M, Hayashi N, Fukushima A, Ueno H. A case of tamoxifen keratopathy. Arch Ophthalmol. 2006, 124:1046-8. 10.1001\/archopht.124.7.1046","journal-title":"Arch Ophthalmol"},{"key":"ref17","doi-asserted-by":"publisher","DOI":"10.1016\/j.ajo.2014.02.046","article-title":"Pseudocystic foveal cavitation in tamoxifen retinopathy","volume":"157","author":"Doshi RR","year":"2014","unstructured":"Doshi RR, Fortun JA, Kim BT, Dubovy SR, Rosenfeld PJ. Pseudocystic foveal cavitation in tamoxifen retinopathy. Am J Ophthalmol. 2014, 157:1291-1298.e3. 10.1016\/j.ajo.2014.02.046","journal-title":"Am J Ophthalmol"},{"key":"ref18","doi-asserted-by":"publisher","DOI":"10.1002\/cncr.21651","article-title":"Ocular toxicity during adjuvant chemoendocrine therapy for early breast cancer: results from International Breast Cancer Study Group trials","volume":"106","author":"Gianni L","year":"2006","unstructured":"Gianni L, Panzini I, Li S, et al.. Ocular toxicity during adjuvant chemoendocrine therapy for early breast cancer: results from International Breast Cancer Study Group trials. Cancer. 2006, 106:505-13. 10.1002\/cncr.21651","journal-title":"Cancer"},{"key":"ref19","doi-asserted-by":"publisher","DOI":"10.1046\/j.1442-9071.2004.00769.x","article-title":"Tamoxifen optic neuropathy","volume":"32","author":"Colley SM","year":"2004","unstructured":"Colley SM, Elston JS. Tamoxifen optic neuropathy. Clin Exp Ophthalmol. 2004, 32:105-6. 10.1046\/j.1442-9071.2004.00769.x","journal-title":"Clin Exp Ophthalmol"},{"key":"ref20","doi-asserted-by":"publisher","DOI":"10.3109\/02713683.2011.594202","article-title":"Breast cancer medications and vision: effects of treatments for early-stage disease","volume":"36","author":"Eisner A","year":"2011","unstructured":"Eisner A, Luoh SW. Breast cancer medications and vision: effects of treatments for early-stage disease. Curr Eye Res. 2011, 36:867-85. 10.3109\/02713683.2011.594202","journal-title":"Curr Eye Res"},{"key":"ref21","doi-asserted-by":"publisher","DOI":"10.1080\/02713680600602547","article-title":"Small optic cup sizes among women using tamoxifen: assessment with scanning laser ophthalmoscopy","volume":"31","author":"Eisner A","year":"2006","unstructured":"Eisner A, O'Malley JP, Incognito LJ, Toomey MD, Samples JR. Small optic cup sizes among women using tamoxifen: assessment with scanning laser ophthalmoscopy. Curr Eye Res. 2006, 31:367-79. 10.1080\/02713680600602547","journal-title":"Curr Eye Res"},{"key":"ref22","doi-asserted-by":"publisher","DOI":"10.3109\/08820539209065094","article-title":"Electrophysiological evaluation of the neuro-ophthalmology patient: an algorithm for clinical use","volume":"7","author":"Brigell M","year":"1992","unstructured":"Brigell M, Celesia GG. Electrophysiological evaluation of the neuro-ophthalmology patient: an algorithm for clinical use. Semin Ophthalmol. 1992, 7:65-78. 10.3109\/08820539209065094","journal-title":"Semin Ophthalmol"},{"key":"ref23","doi-asserted-by":"publisher","DOI":"10.1212\/wnl.40.6.919","article-title":"Optic neuritis: a prospective study","volume":"40","author":"Celesia GG","year":"1990","unstructured":"Celesia GG, Kaufman DI, Brigell M, Toleikis S, Kokinakis D, Lorance R, Lizano B. Optic neuritis: a prospective study. Neurology. 1990, 40:919-23. 10.1212\/wnl.40.6.919","journal-title":"Neurology"},{"key":"ref24","doi-asserted-by":"publisher","DOI":"10.1002\/em.10062","article-title":"Recent trends in breast cancer incidence and mortality","volume":"39","author":"Lacey JV Jr","year":"2002","unstructured":"Lacey JV Jr, Devesa SS, Brinton LA. Recent trends in breast cancer incidence and mortality. Environ Mol Mutagen. 2002, 39:82-8. 10.1002\/em.10062","journal-title":"Environ Mol Mutagen"},{"key":"ref25","doi-asserted-by":"publisher","DOI":"10.1186\/1471-2407-2-37","article-title":"Global and regional estimates of cancer mortality and incidence by site: II. Results for the global burden of disease 2000","volume":"2","author":"Shibuya K","year":"2002","unstructured":"Shibuya K, Mathers CD, Boschi-Pinto C, Lopez AD, Murray CJ. Global and regional estimates of cancer mortality and incidence by site: II. Results for the global burden of disease 2000. BMC Cancer. 2002, 2:37. 10.1186\/1471-2407-2-37","journal-title":"BMC Cancer"},{"key":"ref26","doi-asserted-by":"publisher","DOI":"10.1002\/ijc.21109","article-title":"Geographic pathology revisited: development of an atlas of cancer in India","volume":"116","author":"Nandakumar A","year":"2005","unstructured":"Nandakumar A, Gupta PC, Gangadharan P, Visweswara RN, Parkin DM. Geographic pathology revisited: development of an atlas of cancer in India. Int J Cancer. 2005, 116:740-54. 10.1002\/ijc.21109","journal-title":"Int J Cancer"},{"key":"ref27","doi-asserted-by":"publisher","DOI":"10.1038\/sj.bjp.0706399","article-title":"Tamoxifen (ICI46,474) as a targeted therapy to treat and prevent breast cancer","volume":"147 Suppl 1","author":"Jordan VC","year":"2006","unstructured":"Jordan VC. Tamoxifen (ICI46,474) as a targeted therapy to treat and prevent breast cancer. Br J Pharmacol. 2006, 147 Suppl 1:S269-76. 10.1038\/sj.bjp.0706399","journal-title":"Br J Pharmacol"},{"key":"ref28","doi-asserted-by":"publisher","DOI":"10.1111\/j.1476-5381.1993.tb13840.x","article-title":"Fourteenth Gaddum Memorial Lecture. A current view of tamoxifen for the treatment and prevention of breast cancer","volume":"110","author":"Jordan VC","year":"1993","unstructured":"Jordan VC. Fourteenth Gaddum Memorial Lecture. A current view of tamoxifen for the treatment and prevention of breast cancer. Br J Pharmacol. 1993, 110:507-17. 10.1111\/j.1476-5381.1993.tb13840.x","journal-title":"Br J Pharmacol"},{"key":"ref29","doi-asserted-by":"publisher","DOI":"10.2165\/00003495-197816010-00001","article-title":"Tamoxifen: a review of its pharmacological properties and therapeutic use in the treatment of breast cancer","volume":"16","author":"Heel RC","year":"1978","unstructured":"Heel RC, Brogden RN, Speight TM, Avery GS. Tamoxifen: a review of its pharmacological properties and therapeutic use in the treatment of breast cancer. Drugs. 1978, 16:1-24. 10.2165\/00003495-197816010-00001","journal-title":"Drugs"},{"key":"ref30","doi-asserted-by":"publisher","DOI":"10.1016\/S0140-6736(12)61963-1","article-title":"Long-term effects of continuing adjuvant tamoxifen to 10 years versus stopping at 5 years after diagnosis of oestrogen receptor-positive breast cancer: ATLAS, a randomised trial","volume":"381","author":"Davies C","year":"2013","unstructured":"Davies C, Pan H, Godwin J, et al.. Long-term effects of continuing adjuvant tamoxifen to 10 years versus stopping at 5 years after diagnosis of oestrogen receptor-positive breast cancer: ATLAS, a randomised trial. Lancet. 2013, 381:805-16. 10.1016\/S0140-6736(12)61963-1","journal-title":"Lancet"}],"container-title":["Cureus"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.cureus.com\/articles\/77993-evaluation-of-optic-nerve-head-parameters-and-electro-physiology-among-breast-cancer-patients-on-tamoxifen","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,2,9]],"date-time":"2024-02-09T19:35:19Z","timestamp":1707507319000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.cureus.com\/articles\/77993-evaluation-of-optic-nerve-head-parameters-and-electro-physiology-among-breast-cancer-patients-on-tamoxifen"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,1,9]]},"references-count":30,"URL":"https:\/\/doi.org\/10.7759\/cureus.21042","relation":{},"ISSN":["2168-8184"],"issn-type":[{"value":"2168-8184","type":"print"}],"subject":[],"published":{"date-parts":[[2022,1,9]]}}}